FDA’s Latest PSGs Include Wegovy Generics
New Generic Development Guidance Documents Also Cover Duobrii And Radicava ORS
A fresh batch of product-specific guidances to aid generics development has been published by the US Food and Drug Administration, including new documents covering Wegovy, Duobrii and Radicava ORS, as well as revised PSGs for Celestone Soluspan and Gralise.